SCHEMBL310847

SCHEMBL310847

N#CCc1cccc(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.56
TAAR1 Q96RJ0 1/20 0.50
IDO1 P14902 3/20 0.48
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45
GRIA1 P42261 1/20 0.44
CACNG8 Q8WXS5 1/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
CYP2A13 Q16696 2/20 0.41
HPGD P15428 1/20 0.40
P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763190 1.00 PNMT (0.56) PNMTTAAR1IDO1KMT2AMEN1
SCHEMBL8660405 0.89 ALDH1A1 (0.44) PNMTTAAR1IDO1KMT2AMEN1
SCHEMBL1020369 0.82 IDO1 (0.50) PNMTTAAR1IDO1CYP1A2CYP3A4
SCHEMBL1294116 0.81 GRIA1 (0.43) PNMTTAAR1IDO1KMT2AMEN1
SCHEMBL11306456 0.80 CYP2A6 (0.37) PNMTKMT2AMEN1CYP1A2CYP3A4
Methane SCHEMBL4744157 0.80 IDO1 (0.48) PNMTTAAR1IDO1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL7824228 0.80 IDO1 (0.48) PNMTTAAR1IDO1CYP1A2CYP3A4
SCHEMBL10392251 0.79 CYP2A6 (0.52) PNMTTAAR1IDO1KMT2AMEN1
SCHEMBL1396993 0.79 ALDH1A1 (0.43) PNMTKMT2AMEN1CYP1A2CYP3A4
SCHEMBL4987170 0.79 TAAR1 (0.57) PNMTTAAR1IDO1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-215028650-U Reaction kettle for preparing dichlorobenzyl cyanide 浙江东海新材料科技股份有限公司 2021-12-07 CN claimed
CN-108709944-B Method for simultaneously detecting 6 chlorobenzene acetonitrile serving as nitrogenous aromatic disinfection by-product in drinking water 同济大学 2021-02-12 CN claimed
CN-109613155-A A kind of detection method of armaticity nitrogenous disinfection byproducts 同济大学 2019-04-12 CN claimed
EP-0823904-A4 PROCESS FOR THE PREPARATION OF SPIROINDOLINES MERCK & CO INC (US) 1998-09-09 EP claimed
EP-0823904-A1 PROCESS FOR THE PREPARATION OF SPIROINDOLINES Merck & Co., Inc. (US) 1998-02-18 EP claimed
WO-1996033189-A1 PROCESS FOR THE PREPARATION OF SPIROINDOLINES MERCK & CO., INC. (US) 1996-10-24 WO claimed
JP-6340595-A None JP disclosed
CN-111253404-B Nitrogen-containing heterocyclic compound and composition, preparation method and application thereof 上海医药集团股份有限公司 2023-05-23 CN disclosed
US-11623919-B2 Heterocyclic P2X7 antagonists BREYE THERAPEUTICS APS (DK) 2023-04-11 US disclosed
EP-3362445-B1 OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2023-01-25 EP disclosed
EP-3362445-B1 OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2023-01-25 EP disclosed
CN-110041261-B Preparation method of naphazoline hydrochloride 广东先强药业有限公司 2022-06-24 CN disclosed
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed
CN-1052306-A Compounds having pharmacological activity on the central nervous system WELLCOME FOUND (GB) 1991-06-19 CN disclosed
EP-0372934-A2 Pharmacologically active CNS compounds THE WELLCOME FOUNDATION LIMITED (GB) 1990-06-13 EP disclosed
EP-0044119-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE STAMICARBON B.V. (NL) 1985-05-29 EP disclosed
EP-0034415-B1 1-(CYCLOHEXYL OR CYCLOHEXENYL)-4-ARYL-4-PIPERIDINECARBOXYLIC ACID DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1984-05-30 EP disclosed
US-4435552-A COORDINATION CATALYST CONTAINING HALOACYL COMPOUND STAMICARBON B.V. (NL) 1984-03-06 US disclosed
EP-0044119-A2 Process for the preparation of copolymers of ethylene with at least one other 1-alkene STAMICARBON B.V. (NL) 1982-01-20 EP disclosed
US-3979444-A CENTRAL NERVOUS SYSTEM DEPRESSANTS, HYPOTENSIVES THE UPJOHN COMPANY (US) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11623919-B2 Heterocyclic P2X7 antagonists P2RY1, P2RX1, P2RX3 PNMT 3106/4885TAAR1 240/4885IDO1 1048/4885
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 PNMT 1235/4885TAAR1 3624/4885IDO1 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.